MedCap AB (publ) (FRA:61MA)

MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of EUR 754.95 million. The enterprise value is 768.96 million.

Market Cap	754.95M
Enterprise Value	768.96M

Important Dates

The next estimated earnings date is Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	14.99M
Shares Outstanding	n/a
Shares Change (YoY)	+0.18%
Shares Change (QoQ)	-0.19%
Owned by Insiders (%)	1.20%
Owned by Institutions (%)	62.81%
Float	11.84M

Valuation Ratios

The trailing PE ratio is 42.39.

PE Ratio	42.39
Forward PE	n/a
PS Ratio	4.19
PB Ratio	5.94
P/TBV Ratio	25.96
P/FCF Ratio	28.42
P/OCF Ratio	26.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.60, with an EV/FCF ratio of 28.95.

EV / Earnings	43.18
EV / Sales	4.24
EV / EBITDA	22.60
EV / EBIT	33.02
EV / FCF	28.95

Financial Position

The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.36.

Current Ratio	2.34
Quick Ratio	1.63
Debt / Equity	0.36
Debt / EBITDA	1.36
Debt / FCF	1.72
Interest Coverage	13.04

Financial Efficiency

Return on equity (ROE) is 15.25% and return on invested capital (ROIC) is 9.24%.

Return on Equity (ROE)	15.25%
Return on Assets (ROA)	7.30%
Return on Invested Capital (ROIC)	9.24%
Return on Capital Employed (ROCE)	12.49%
Revenue Per Employee	304,324
Profits Per Employee	30,084
Employee Count	592
Asset Turnover	0.91
Inventory Turnover	2.92

Taxes

In the past 12 months, MedCap AB has paid 5.30 million in taxes.

Income Tax	5.30M
Effective Tax Rate	22.79%

Stock Price Statistics

The stock price has increased by +8.95% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+8.95%
50-Day Moving Average	51.42
200-Day Moving Average	45.13
Relative Strength Index (RSI)	50.25
Average Volume (20 Days)	1

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of EUR 180.16 million and earned 17.81 million in profits. Earnings per share was 1.19.

Revenue	180.16M
Gross Profit	104.63M
Operating Income	23.12M
Pretax Income	23.25M
Net Income	17.81M
EBITDA	30.39M
EBIT	23.12M
Earnings Per Share (EPS)	1.19

Balance Sheet

The company has 32.44 million in cash and 45.78 million in debt, giving a net cash position of -13.33 million.

Cash & Cash Equivalents	32.44M
Total Debt	45.78M
Net Cash	-13.33M
Net Cash Per Share	n/a
Equity (Book Value)	127.17M
Book Value Per Share	8.45
Working Capital	52.53M

Cash Flow

In the last 12 months, operating cash flow was 28.73 million and capital expenditures -2.16 million, giving a free cash flow of 26.57 million.

Operating Cash Flow	28.73M
Capital Expenditures	-2.16M
Free Cash Flow	26.57M
FCF Per Share	n/a

Margins

Gross margin is 58.08%, with operating and profit margins of 12.83% and 9.89%.

Gross Margin	58.08%
Operating Margin	12.83%
Pretax Margin	12.91%
Profit Margin	9.89%
EBITDA Margin	16.87%
EBIT Margin	12.83%
FCF Margin	14.75%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.18%
Shareholder Yield	-0.18%
Earnings Yield	2.36%
FCF Yield	3.52%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4